{"id":"W4385999452","doi":"10.1038/s41375-023-02006-8","title":"Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Leukemia","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; Simon Fraser University","funders":"Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; U.S. Department of Health and Human Services; National Cancer Institute; National Institutes of Health; Department of Biotechnology, Ministry of Science and Technology, India; Ohio State University","keywords":"Mantle cell lymphoma; Cancer research; Fibroblast growth factor receptor 1; In vivo; Biology; Lymphoma; Cell growth; Cell cycle checkpoint; Cell cycle; Medicine; Fibroblast growth factor; Immunology; Cancer; Receptor; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005575833,0.0002619473,0.0001816645,0.0001029111,0.0002934024,0.0001320417,0.0007169959,0.0002168558,0.00004869817],"category_scores_gemma":[0.0004550139,0.0001700146,0.0001119777,0.0007636314,0.0001357684,0.00001642258,0.0004255011,0.000311127,0.0002947178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002762472,"about_ca_system_score_gemma":0.000357976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001481513,"about_ca_topic_score_gemma":0.0001666712,"domain_scores_codex":[0.9974298,0.0004691328,0.0003811248,0.0006107671,0.0004396361,0.0006695341],"domain_scores_gemma":[0.9987159,0.0002009687,0.00007814971,0.0007364328,0.0001383771,0.0001301225],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002011301,0.00005519839,0.01445142,0.00005854863,0.0000270241,0.000005153368,0.0007227779,0.0005833626,0.9764495,0.0001196265,0.004731943,0.00259429],"study_design_scores_gemma":[0.001303317,0.0006038593,0.2017278,0.00007227362,0.000007951343,0.00000790359,0.000629297,0.001853468,0.7819352,0.0002314578,0.01115603,0.0004715584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958949,0.00003731315,0.0002622484,0.001894585,0.0001003075,0.0009037631,0.00004549756,0.00006262386,0.0007987303],"genre_scores_gemma":[0.9979114,0.00005136016,0.0001661647,0.0004496847,0.0003049699,0.0002408065,0.0001116885,0.0000557015,0.0007082371],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1945144,"threshold_uncertainty_score":0.6932994,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0239461135196629,"score_gpt":0.279543061903347,"score_spread":0.2555969483836841,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}